Fosravuconazole

Fosravuconazole
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Fosravuconazole is an antifungal medication used in the treatment of various fungal infections. It is a prodrug of ravuconazole, which means it is converted into the active form in the body. Fosravuconazole is known for its broad-spectrum activity against a range of fungal pathogens.

Mechanism of Action

Fosravuconazole works by inhibiting the synthesis of ergosterol, a critical component of fungal cell membranes. By disrupting the production of ergosterol, fosravuconazole compromises the integrity of the fungal cell membrane, leading to cell death. This mechanism is similar to other azole antifungals.

Pharmacokinetics

Fosravuconazole is administered orally and is absorbed in the gastrointestinal tract. Once absorbed, it is converted into ravuconazole, the active form. The conversion process allows for sustained levels of the active drug in the bloodstream, which is beneficial for treating chronic fungal infections.

Clinical Uses

Fosravuconazole is primarily used to treat onychomycosis, a fungal infection of the nails. It is also effective against other fungal infections such as candidiasis and aspergillosis. Its broad-spectrum activity makes it a valuable option in antifungal therapy.

Side Effects

Common side effects of fosravuconazole include nausea, headache, and abdominal pain. Like other azole antifungals, it may also cause liver enzyme abnormalities, so liver function should be monitored during treatment.

Related pages

• Antifungal medication
• Azole antifungals
• Ravuconazole

• 
  Fosravuconazole